A Mechanistic, Stochastic Model Helps Understand Multiple Sclerosis Course and Pathogenesis

Figure 3

Histogram of the duration of the relapsing-remitting phase in weeks for the 70 selected patients. The duration of the relapsing-remitting phase (i.e., analysis period) varies from one patient to the other, from a minimum of 40 weeks to a maximum of 1311 weeks, following an exponential decaying distribution. For 25 of 70 selected patients (about 36%), the relapsing-remitting phase lasts for about 200 weeks (about 4 years).